Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

The use of genomic DNA sequences as type material for valid publication of bacterial species names will have severe implications for clinical microbiology and related disciplines.

Bisgaard M, Christensen H, Clermont D, Dijkshoorn L, Janda JM, Moore ERB, Nemec A, Nørskov-Lauritsen N, Overmann J, Reubsaet FAG.

Diagn Microbiol Infect Dis. 2019 Mar 22. pii: S0732-8893(19)30242-1. doi: 10.1016/j.diagmicrobio.2019.03.007. [Epub ahead of print] No abstract available.

PMID:
30981555
2.

Pulmonary vein anatomy addressed by computed tomography and relation to success of second-generation cryoballoon ablation in paroxysmal atrial fibrillation.

Mulder BA, Al-Jazairi MIH, Arends BKO, Bax N, Dijkshoorn LA, Sheikh U, Tan ES, Wiesfeld ACP, Tieleman RG, Vliegenthart R, Rienstra M, van Gelder IC, Blaauw Y.

Clin Cardiol. 2019 Apr;42(4):438-443. doi: 10.1002/clc.23163. Epub 2019 Mar 13.

3.

International Committee on Systematics of Prokaryotes. Minutes of the meetings, 7, 8 and 9 July 2017, Valencia, Spain.

Dijkshoorn L.

Int J Syst Evol Microbiol. 2018 Jun;68(6):2104-2110. doi: 10.1099/ijsem.0.002787. Epub 2018 Apr 24. No abstract available.

PMID:
29688168
4.

Occurrence of IMP-1 in non-baumannii Acinetobacter clinical isolates from Brazil.

Cayô R, Streling AP, Nodari CS, Matos AP, de Paula Luz A, Dijkshoorn L, Pignatari ACC, Gales AC.

J Med Microbiol. 2018 May;67(5):628-630. doi: 10.1099/jmm.0.000732. Epub 2018 Apr 6.

PMID:
29624159
5.

Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.

Presta L, Bosi E, Mansouri L, Dijkshoorn L, Fani R, Fondi M.

Sci Rep. 2017 Jun 16;7(1):3706. doi: 10.1038/s41598-017-03416-2.

6.

MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species.

Marí-Almirall M, Cosgaya C, Higgins PG, Van Assche A, Telli M, Huys G, Lievens B, Seifert H, Dijkshoorn L, Roca I, Vila J.

Clin Microbiol Infect. 2017 Mar;23(3):210.e1-210.e9. doi: 10.1016/j.cmi.2016.11.020. Epub 2016 Dec 3.

7.

Phylogenetic signal in phenotypic traits related to carbon source assimilation and chemical sensitivity in Acinetobacter species.

Van Assche A, Álvarez-Pérez S, de Breij A, De Brabanter J, Willems KA, Dijkshoorn L, Lievens B.

Appl Microbiol Biotechnol. 2017 Jan;101(1):367-379. doi: 10.1007/s00253-016-7866-0. Epub 2016 Oct 12.

PMID:
27734121
8.

Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.

De Vos D, Pirnay JP, Bilocq F, Jennes S, Verbeken G, Rose T, Keersebilck E, Bosmans P, Pieters T, Hing M, Heuninckx W, De Pauw F, Soentjens P, Merabishvili M, Deschaght P, Vaneechoutte M, Bogaerts P, Glupczynski Y, Pot B, van der Reijden TJ, Dijkshoorn L.

PLoS One. 2016 May 25;11(5):e0156237. doi: 10.1371/journal.pone.0156237. eCollection 2016.

9.

Genomic and phenotypic characterization of the species Acinetobacter venetianus.

Fondi M, Maida I, Perrin E, Orlandini V, La Torre L, Bosi E, Negroni A, Zanaroli G, Fava F, Decorosi F, Giovannetti L, Viti C, Vaneechoutte M, Dijkshoorn L, Fani R.

Sci Rep. 2016 Feb 23;6:21985. doi: 10.1038/srep21985.

10.

Old Clinical Isolates of Acinetobacter seifertii in Brazil Producing OXA-58.

Cayô R, Rodrigues-Costa F, Pereira Matos A, Godoy Carvalhaes C, Dijkshoorn L, Gales AC.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2589-91. doi: 10.1128/AAC.01957-15. Print 2016 Apr. No abstract available.

11.

Phylogenetic and genomic diversity in isolates from the globally distributed Acinetobacter baumannii ST25 lineage.

Sahl JW, Del Franco M, Pournaras S, Colman RE, Karah N, Dijkshoorn L, Zarrilli R.

Sci Rep. 2015 Oct 14;5:15188. doi: 10.1038/srep15188.

12.

Metabolic engineering of Bacillus subtilis for terpenoid production.

Guan Z, Xue D, Abdallah II, Dijkshoorn L, Setroikromo R, Lv G, Quax WJ.

Appl Microbiol Biotechnol. 2015 Nov;99(22):9395-406. doi: 10.1007/s00253-015-6950-1. Epub 2015 Sep 15. Review.

13.

Identification of NDM-1 in a Putatively Novel Acinetobacter Species ("NB14") Closely Related to Acinetobacter pittii.

Espinal P, Mosqueda N, Telli M, van der Reijden T, Rolo D, Fernández-Orth D, Dijkshoorn L, Roca I, Vila J.

Antimicrob Agents Chemother. 2015 Oct;59(10):6657-60. doi: 10.1128/AAC.01455-15. Epub 2015 Aug 10.

14.

Carbapenem resistance in a human clinical isolate identified to be closely related to Acinetobacter indicus.

Bonnin RA, Poirel L, van der Reijden TJ, Dijkshoorn L, Lescat M, Nordmann P.

Int J Antimicrob Agents. 2014 Oct;44(4):345-50. doi: 10.1016/j.ijantimicag.2014.05.022. Epub 2014 Jul 19.

PMID:
25245212
15.

Characterization of a novel international clonal complex (CC32) of Acinetobacter baumannii with epidemic potential.

Da Silva GJ, Van Der Reijden T, Domingues S, Mendonça N, Petersen K, Dijkshoorn L.

Epidemiol Infect. 2014 Jul;142(7):1554-8. doi: 10.1017/S0950268813002288. Epub 2013 Sep 30.

PMID:
24074290
16.

Acinetobacter kookii sp. nov., isolated from soil.

Choi JY, Ko G, Jheong W, Huys G, Seifert H, Dijkshoorn L, Ko KS.

Int J Syst Evol Microbiol. 2013 Dec;63(Pt 12):4402-6. doi: 10.1099/ijs.0.047969-0. Epub 2013 Aug 15.

PMID:
23950148
17.

Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme.

Hu D, Liu B, Dijkshoorn L, Wang L, Reeves PR.

PLoS One. 2013 Jul 29;8(7):e70329. doi: 10.1371/journal.pone.0070329. Print 2013.

18.

The genome sequence of the hydrocarbon-degrading Acinetobacter venetianus VE-C3.

Fondi M, Rizzi E, Emiliani G, Orlandini V, Berna L, Papaleo MC, Perrin E, Maida I, Corti G, De Bellis G, Baldi F, Dijkshoorn L, Vaneechoutte M, Fani R.

Res Microbiol. 2013 Jun;164(5):439-49. doi: 10.1016/j.resmic.2013.03.003. Epub 2013 Mar 23.

PMID:
23528645
19.

Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T.

Koning RI, de Breij A, Oostergetel GT, Nibbering PH, Koster AJ, Dijkshoorn L.

Res Microbiol. 2013 Jun;164(5):397-405. doi: 10.1016/j.resmic.2013.02.007. Epub 2013 Mar 19.

PMID:
23517882
20.

Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey.

Metan G, Sariguzel F, Sumerkan B, Reijden Tv, Dijkshoorn L.

Infect Genet Evol. 2013 Mar;14:92-7. doi: 10.1016/j.meegid.2012.11.003. Epub 2012 Dec 1. Erratum in: Infect Genet Evol. 2013 Jun;16:447-8.

PMID:
23207178
21.

The success of acinetobacter species; genetic, metabolic and virulence attributes.

Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L.

PLoS One. 2012;7(10):e46984. doi: 10.1371/journal.pone.0046984. Epub 2012 Oct 29.

22.

Draft genome sequence of the hydrocarbon-degrading and emulsan-producing strain Acinetobacter venetianus RAG-1T.

Fondi M, Orlandini V, Emiliani G, Papaleo MC, Maida I, Perrin E, Vaneechoutte M, Dijkshoorn L, Fani R.

J Bacteriol. 2012 Sep;194(17):4771-2. doi: 10.1128/JB.01019-12.

23.

Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia.

de Breij A, Eveillard M, Dijkshoorn L, van den Broek PJ, Nibbering PH, Joly-Guillou ML.

PLoS One. 2012;7(2):e30673. doi: 10.1371/journal.pone.0030673. Epub 2012 Feb 8.

24.

Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization.

de Breij A, Haisma EM, Rietveld M, El Ghalbzouri A, van den Broek PJ, Dijkshoorn L, Nibbering PH.

Antimicrob Agents Chemother. 2012 May;56(5):2459-64. doi: 10.1128/AAC.05975-11. Epub 2012 Jan 30.

25.

Molecular and phenotypic characterization of Acinetobacter strains able to degrade diesel fuel.

Mara K, Decorosi F, Viti C, Giovannetti L, Papaleo MC, Maida I, Perrin E, Fondi M, Vaneechoutte M, Nemec A, van den Barselaar M, Dijkshoorn L, Fani R.

Res Microbiol. 2012 Apr;163(3):161-72. doi: 10.1016/j.resmic.2011.12.002. Epub 2011 Dec 16.

PMID:
22210401
26.

Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS.

Espinal P, Seifert H, Dijkshoorn L, Vila J, Roca I.

Clin Microbiol Infect. 2012 Nov;18(11):1097-103. doi: 10.1111/j.1469-0691.2011.03696.x. Epub 2011 Nov 15.

27.

Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany.

Zordan S, Prenger-Berninghoff E, Weiss R, van der Reijden T, van den Broek P, Baljer G, Dijkshoorn L.

Emerg Infect Dis. 2011 Sep;17(9):1751-4. doi: 10.3201/eid1709.101931.

28.

Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore.

Koh TH, Tan TT, Khoo CT, Ng SY, Tan TY, Hsu LY, Ooi EE, Van Der Reijden TJ, Dijkshoorn L.

Epidemiol Infect. 2012 Mar;140(3):535-8. doi: 10.1017/S0950268811001129. Epub 2011 Jun 21.

PMID:
21733253
29.

Widespread carbapenem resistant Acinetobacter baumannii clones in Italian hospitals revealed by a multicenter study.

Carretto E, Barbarini D, Dijkshoorn L, van der Reijden TJ, Brisse S, Passet V, Farina C; APSI Acinetobacter Study Group.

Infect Genet Evol. 2011 Aug;11(6):1319-26. doi: 10.1016/j.meegid.2011.04.024. Epub 2011 Apr 29.

PMID:
21554997
30.

Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I.

Krizova L, Dijkshoorn L, Nemec A.

Antimicrob Agents Chemother. 2011 Jul;55(7):3201-6. doi: 10.1128/AAC.00221-11. Epub 2011 May 2.

31.

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU).

Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L.

Res Microbiol. 2011 May;162(4):393-404. doi: 10.1016/j.resmic.2011.02.006. Epub 2011 Feb 12.

PMID:
21320596
32.

Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center.

Petersen K, Cannegieter SC, van der Reijden TJ, van Strijen B, You DM, Babel BS, Philip AI, Dijkshoorn L.

J Clin Microbiol. 2011 Jan;49(1):159-66. doi: 10.1128/JCM.00766-10. Epub 2010 Nov 17.

33.

Microbial systematics and taxonomy: relevance for a microbial commons.

Moore ER, Mihaylova SA, Vandamme P, Krichevsky MI, Dijkshoorn L.

Res Microbiol. 2010 Jul-Aug;161(6):430-8. doi: 10.1016/j.resmic.2010.05.007. Epub 2010 Jun 1. Review.

PMID:
20670913
34.

Understanding patterns of use and scientific opportunities in the emerging global microbial commons.

Dijkshoorn L, De Vos P, Dedeurwaerdere T.

Res Microbiol. 2010 Jul-Aug;161(6):407-13. doi: 10.1016/j.resmic.2010.06.001. Epub 2010 Jun 19.

PMID:
20599611
35.

Microbiological material exchanges among scientists.

Staley JT, Fitzgerald K, Fuerst JA, Dijkshoorn L.

Res Microbiol. 2010 Jul-Aug;161(6):446-52. doi: 10.1016/j.resmic.2010.05.011. Epub 2010 Jun 15.

PMID:
20558279
36.

Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?

de Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, Bloemberg G, Wolterbeek R, van den Broek P, Nibbering P.

PLoS One. 2010 May 20;5(5):e10732. doi: 10.1371/journal.pone.0010732.

37.

The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.

Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S.

PLoS One. 2010 Apr 7;5(4):e10034. doi: 10.1371/journal.pone.0010034.

38.

Exploring the evolutionary dynamics of plasmids: the Acinetobacter pan-plasmidome.

Fondi M, Bacci G, Brilli M, Papaleo MC, Mengoni A, Vaneechoutte M, Dijkshoorn L, Fani R.

BMC Evol Biol. 2010 Feb 24;10:59. doi: 10.1186/1471-2148-10-59.

39.

Variations in colistin susceptibility among different species of the genus Acinetobacter.

Nemec A, Dijkshoorn L.

J Antimicrob Chemother. 2010 Feb;65(2):367-9. doi: 10.1093/jac/dkp440. Epub 2009 Dec 11. No abstract available.

PMID:
20008049
40.

Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.

van den Broek PJ, van der Reijden TJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L.

J Clin Microbiol. 2009 Nov;47(11):3593-9. doi: 10.1128/JCM.00967-09. Epub 2009 Sep 30.

41.

Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively.

Nemec A, Musílek M, Sedo O, De Baere T, Maixnerová M, van der Reijden TJ, Zdráhal Z, Vaneechoutte M, Dijkshoorn L.

Int J Syst Evol Microbiol. 2010 Apr;60(Pt 4):896-903. doi: 10.1099/ijs.0.013656-0. Epub 2009 Aug 6.

PMID:
19661501
42.

Quorum sensing signal profile of Acinetobacter strains from nosocomial and environmental sources.

González RH, Dijkshoorn L, Van den Barselaar M, Nudel C.

Rev Argent Microbiol. 2009 Apr-Jun;41(2):73-8.

PMID:
19623895
43.

CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response.

de Breij A, Gaddy J, van der Meer J, Koning R, Koster A, van den Broek P, Actis L, Nibbering P, Dijkshoorn L.

Res Microbiol. 2009 Apr;160(3):213-8. doi: 10.1016/j.resmic.2009.01.002.

PMID:
19530313
44.

Description of Acinetobacter venetianus ex Di Cello et al. 1997 sp. nov.

Vaneechoutte M, Nemec A, Musílek M, van der Reijden TJ, van den Barselaar M, Tjernberg I, Calame W, Fani R, De Baere T, Dijkshoorn L.

Int J Syst Evol Microbiol. 2009 Jun;59(Pt 6):1376-81. doi: 10.1099/ijs.0.003541-0.

PMID:
19502319
45.

OXA-23-type imipenem resistance in Acinetobacter baumannii in Hong Kong.

Chu YW, Cheung TK, Chu MY, Lo JY, Dijkshoorn L.

Int J Antimicrob Agents. 2009 Sep;34(3):285-6. doi: 10.1016/j.ijantimicag.2009.03.010. Epub 2009 Apr 24. No abstract available.

PMID:
19394202
46.

Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species.

Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B.

Microbiology. 2009 Jul;155(Pt 7):2333-41. doi: 10.1099/mic.0.026054-0. Epub 2009 Apr 23.

PMID:
19389786
47.

Identification of non-fermenting Gram-negative bacteria of clinical importance by an oligonucleotide array.

Su SC, Vaneechoutte M, Dijkshoorn L, Wei YF, Chen YL, Chang TC.

J Med Microbiol. 2009 May;58(Pt 5):596-605. doi: 10.1099/jmm.0.004606-0.

PMID:
19369521
48.

Identification of Acinetobacter genomic species 13TU by sequence analysis of the 16S-23S rRNA gene spacer region.

Zarrilli R, Giannouli M, Di Popolo A, Tomasone F, Chu YW, Vaneechoutte M, Dijkshoorn L, Chang TC.

J Clin Microbiol. 2009 Apr;47(4):1281-2. doi: 10.1128/JCM.02022-08. No abstract available.

49.

Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans.

Nemec A, Musílek M, Maixnerová M, De Baere T, van der Reijden TJ, Vaneechoutte M, Dijkshoorn L.

Int J Syst Evol Microbiol. 2009 Jan;59(Pt 1):118-24. doi: 10.1099/ijs.0.001230-0.

PMID:
19126734
50.

Can Escherichia coli be used as an indicator organism for transmission events in hospitals?

van den Broek PJ, Bernards AT, van der Reijden TJ, van Strijen B, Dijkshoorn L.

Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):169-73. doi: 10.1007/s10096-008-0597-0. Epub 2008 Aug 6.

PMID:
18682996

Supplemental Content

Loading ...
Support Center